Covered recipient · General Payments record
TIMOTHY K HUYCK
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2019–2025
$956.07
- Reported across 50 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $252.46 | 13 |
| Education | $43.42 | 2 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Daiichi Sankyo Inc. | $68.07 | 3 |
| ABBVIE INC. | $54.06 | 2 |
| E.R. Squibb & Sons, L.L.C. | $48.20 | 3 |
| PFIZER INC. | $25.30 | 1 |
| Astellas Pharma US Inc | $18.12 | 1 |
| Caris MPI, Inc. | $17.95 | 1 |
| Octapharma USA, Inc. | $17.55 | 1 |
| Acerta Pharma LLC | $17.37 | 1 |
| Rigel Pharmaceuticals, Inc. | $15.44 | 1 |
| Janssen Biotech, Inc. | $13.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.33 | 04/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202086930 | CMS |
| ABBVIE INC. | $22.73 | 08/15/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1202086932 | CMS |
| Astellas Pharma US Inc | $18.12 | 04/24/2025 | Education | Undisputed | 06/30/2026 | 1238638486 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.37 | 09/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1207053066 | CMS |
| Caris MPI, Inc. | $17.95 | 12/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1234281345 | CMS |
| Daiichi Sankyo Inc. | $24.83 | 05/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197088235 | CMS |
| Daiichi Sankyo Inc. | $23.86 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197078477 | CMS |
| Daiichi Sankyo Inc. | $19.38 | 11/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1197005071 | CMS |
| E.R. Squibb & Sons, L.L.C. | $17.95 | 01/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184781971 | CMS |
| E.R. Squibb & Sons, L.L.C. | $15.80 | 04/02/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184781987 | CMS |
| E.R. Squibb & Sons, L.L.C. | $14.45 | 07/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1184782011 | CMS |
| Janssen Biotech, Inc. | $13.82 | 07/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1175146226 | CMS |
| Octapharma USA, Inc. | $17.55 | 10/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1245078681 | CMS |
| PFIZER INC. | $25.30 | 10/16/2025 | Education | Undisputed | 06/30/2026 | 1230189073 | CMS |
| Rigel Pharmaceuticals, Inc. | $15.44 | 06/03/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1247374323 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.